By
Damjanovic
Published: July 8, 2012, 11:20 a.m.·
Tags:
None
American SME Sequella Inc. is looking for partners for preclinical and early clinical development of new drug candidates for the treatment of multidrug-resistant tuberculosis (MDR-TB) under FP7 (or even Eurostars).
Read More →